Skip to content

Detection of cardiac fibrosis by LGE MRI and circulating biomarkers in patients with myocardial infarction.

Detection of cardiac fibrosis by LGE MRI and circulating biomarkers in patients with myocardial infarction. - DEFI-MI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44735
Enrollment
78
Registered
2013-11-12
Start date
2014-03-31
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subject is diagnosed with acute myocardial infarction. Subject is 18 years or older.

Exclusion criteria

Exclusion criteria: Subject with known prior acute myocardial infarction, cardiac surgery, or valvular diseases. Subject is implanted with MRI incompatible prostheses or devices. Subject has an indication for implantable cardio defibrillator. Subject is in a condition that alters the collagen turnover. Subject underwent recent trauma or surgery in the last 6 months. Subject is diagnosed with kidney failure. Subject is known with an allergy against gadolinium-based contrast agents. Subject is familiar with claustrophobia. Subject is pregnant or has given birth within the past 90 days.

Design outcomes

Primary

MeasureTime frame
- Cardiac fibrosis determined by contrast MRI at 4-6 months after myocardial infarction. - Circulating biomarkers (related to fibrosis) at 4-6 months after myocardial infarction.

Secondary

MeasureTime frame
- Circulating biomarkers (related to fibrosis) at other time points. - New circulating biomarkers (related to fibrosis and cardiac function) - Cardiac function - Death - Composite endpoint of non-fatal myocardial infarction, stroke, cardiovascular hospitalisation or cardiovascular death. - Heart failure - Fibrosis determined with new MRI techniques

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)